Effects of Dopamine D2/D3 Blockade on Human Sensory and Sensorimotor Gating in Initially Antipsychotic-Naive, First-Episode Schizophrenia Patients

Improvement of Brain Reward Abnormalities by Antipsychotic Monotherapy in Schizophrenia

(2012) Mette Odegaard Nielsen et al.   ARCHIVES OF GENERAL PSYCHIATRY

Alterations of the Brain Reward System in Antipsychotic Naïve Schizophrenia Patients

(2012) Mette Ødegaard Nielsen et al.   BIOLOGICAL PSYCHIATRY

Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach

(2012) Christoph Völter et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

P50 Suppression and Its Neural Generators in Antipsychotic-Naïve First-Episode Schizophrenia Before and After 6 Months of Quetiapine Treatment

(2012) Bob Oranje et al.   SCHIZOPHRENIA BULLETIN

Clonidine Normalizes Sensorimotor Gating Deficits in Patients With Schizophrenia on Stable Medication

(2012) Bob Oranje et al.   SCHIZOPHRENIA BULLETIN

Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months’ treatment with quetiapine

(2010) Bodil Aggernaes et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers

(2009) M. Wienberg et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

(2009) Atheir I. Abbas et al.   PSYCHOPHARMACOLOGY

Impaired Sensorimotor Gating of the Acoustic Startle Response in the Prodrome of Schizophrenia

(2008) Boris B. Quednow et al.   BIOLOGICAL PSYCHIATRY

Amisulpride the ‘atypical’ atypical antipsychotic — Comparison to haloperidol, risperidone and clozapine

(2008) Sridhar Natesan et al.   SCHIZOPHRENIA RESEARCH